Usher Syndrome Type Ii
📧 Sign up to get email alerts when something new happens for Usher Syndrome Type Ii.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene [Phase 2]
Ultevursen is being evaluated in a Phase 2 trial for retinitis pigmentosa caused by USH2A exon 13 mutations, and recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) [Phase 2, Phase 3]
The Sirius study evaluating Ultevursen for retinitis pigmentosa due to USH2A exon 13 mutations (Phase 2/3) was terminated, with results post…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste) [Phase 2, Phase 3]
A Phase 2/3 study evaluating QR-421a for retinitis pigmentosa due to USH2A exon 13 mutations was terminated, with results posted in January …
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Study of Usher Syndromes, Type 1 and Type 2
Clinical trial update for Usher syndrome types I and II with Retinitis Pigmentosa as the condition.